Table 3. Univariate and multivariate analysis of factors associated with progression-free survival in cervical cancer patients^a.

Variables	Subset	HR(95%CI)	P-value
Univariate analysis
Age, years	>35 vs. ≤35	0.4(0.2-1.0)	0.055
FIGO stage	IIA/IIB vs.IB1/IB2	1.2(0.5-3.2)	0.649
Greatest tumor dimension, cm	>4 vs. ≤4	0.6(0.2-2.1)	0.476
Lymphovascular space invasion	Yes or no	1.5(0.3-6.3)	0.591
Depth of cervical invasion	≥66% vs. <66%	2.8(0.9-8.7)	0.067
Uterine corpus invasion	Yes or no	1.9(0.8-4.6)	0.137
Pelvic lymph node metastasis	Yes or no	2.9(1.2-6.8)	0.014 a
Differentiation	poor vs. well/moderate	4.5(1.5-13.6)	0.008 a
F. nucleatum level	high vs. low	5.2(1.7-16.1)	0.003 a
Multivariate analysis
Pelvic lymph node metastasis	Yes or no	3.1(1.1-8.8)	0.029 a
Differentiation	poor vs. well/moderate	4.8(1.2-18.3)	0.023 a
F. nucleatum level	high vs. low	4.8(1.2-18.6)	0.024 a